 | Up a level |
2022
Kruger, S. F., Lohneis, A., Abendroth, A., Berger, A. W., Ettrich, T. J., Waidmann, O., Kapp, M., Steiner, B., Kumbrink, J., Reischer, A., Haas, M., Westphalen, C. B., Zhang, D., Miller-Phillips, L., Burger, P. J., Kobold, S., Werner, J., Subklewe, M., Von Bergwelt-Baildon, M., Kunzmann, V, Seufferlein, T., Siveke, J. T., Sinn, M., Heinemann, V, Ormanns, S. and Boeck, S. (2022). Prognosis and tumor biology of pancreatic cancer patients with isolated lung metastases: translational results from the German multicenter AIO-YMO-PAK-0515 study. ESMO Open, 7 (1). AMSTERDAM: ELSEVIER. ISSN 2059-7029
2018
Borchmann, P., Viardot, A., Wermke, M., Subklewe, M., Siddiqi, T., Jaeger, U., Hasskarl, J. and Abramson, J. S. (2018). Results of the phase I transcend NHL 001 trial of JCAR017 support the phase II transcend world study of this Chimeric Antigen Receptor (CAR) T-Cell therapy in patients (Pts) with aggressive B-Cell Non-Hodgkin Lymphoma (B-NHL). Oncol. Res. Treat., 41. S. 37 - 38. BASEL: KARGER. ISSN 2296-5262